Krabbe, T.; Marek, J.; Groll, T.; Steiger, K.; Schmid, R.M.; Krackhardt, A.M.; Altomonte, J.
Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma. Cancers 2021, 13, 1044.
https://doi.org/10.3390/cancers13051044
AMA Style
Krabbe T, Marek J, Groll T, Steiger K, Schmid RM, Krackhardt AM, Altomonte J.
Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma. Cancers. 2021; 13(5):1044.
https://doi.org/10.3390/cancers13051044
Chicago/Turabian Style
Krabbe, Teresa, Janina Marek, Tanja Groll, Katja Steiger, Roland M. Schmid, Angela M. Krackhardt, and Jennifer Altomonte.
2021. "Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma" Cancers 13, no. 5: 1044.
https://doi.org/10.3390/cancers13051044
APA Style
Krabbe, T., Marek, J., Groll, T., Steiger, K., Schmid, R. M., Krackhardt, A. M., & Altomonte, J.
(2021). Adoptive T Cell Therapy Is Complemented by Oncolytic Virotherapy with Fusogenic VSV-NDV in Combination Treatment of Murine Melanoma. Cancers, 13(5), 1044.
https://doi.org/10.3390/cancers13051044